Q4 Revenues of $599 million, up 11% over third quarter, 3% year over year. GAAP EPS of $0.39 in quarterNon-GAAP EPS of $0.52, up 4% year over year – Exceptional preliminary cash flow from operations

NORWALK, Conn., Feb 09, 2010 (BUSINESS WIRE) — IMS Health (NYSE: RX), announced fourth-quarter 2009 revenue of $599.2 million, up 3 percent year over year and down 3 percent constant dollar, compared with $580.9 million in the 2008 fourth quarter. Operating income in the fourth quarter of 2009 was $106.3 million compared to $126.6 million in operating income in the year-earlier period. When adjusted for the restructuring charge, merger costs and certain other items, operating income on a non-GAAP basis for this year’s fourth quarter would have been $134.0 million, compared with $136.0 million in the 2008 fourth quarter (See Note c to the financial tables). basis was $138.0 million, bringing the total for full-year 2009 to $543.1 million Full-Year Results

For the 2009 full year, revenues were $2,189.7 million, down 6 percent or 4 percent constant dollar, compared with revenues of $2,329.5 million in 2008. Including the restructuring charge, certain asset impairments, merger costs and certain other items, operating income for full-year 2009 was $270.9 million, compared to $498.3 million in 2008. When adjusted for these items, operating income on a non-GAAP basis for 2009 would have been $430.4 million, compared with $511.5 million in 2008 (See Note c to the financial tables).  Source: IMS

BIIA Newsletter March II – 2010 Issue